Marks, Peter W <br/><br/>
Clear Evidence of Safety and Efficacy Is Needed for Stromal Vascular Fraction Products: Commentary on "Arguments for a Different Regulatory Categorization and Framework for Stromal Vascular Fraction".  [electronic resource] 

 -  Stem cells and development  03 2020 
 - 263-265 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1557-8534 
<br/><br/><label>Standard No.: </label>10.1089/scd.2020.0011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipose Tissue<br/>Stromal Cells